
==== Front
BMC Surg
BMC Surg
BMC Surgery
1471-2482
BioMed Central London

2547
10.1186/s12893-024-02547-4
Research
Fournier’s Gangrene: clinical case review and analysis of risk factors for mortality
You Qingyun 1
Guan Jing 1
Wu Bensheng 2
Du Jun 2
Miao Yangyang 3
Bai Xinxin 1
Ma Yuhua 1
Zhen Shuguang 49662562@qq.com

2
http://orcid.org/0000-0002-1721-0018
He Zongqi hzq_009@163.com

4
1 grid.410745.3 0000 0004 1765 1045 Nanjing University of Chinese Medicine, Nanjing, 210046 Jiangsu PR China
2 https://ror.org/04523zj19 grid.410745.3 0000 0004 1765 1045 Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009 Jiangsu Province PR China
3 https://ror.org/04523zj19 grid.410745.3 0000 0004 1765 1045 Clinical Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009 PR China
4 https://ror.org/04523zj19 grid.410745.3 0000 0004 1765 1045 Department of Anorectal Surgery, Kunshan Hospital Affiliated to Nanjing University of Chinese Medicine, Kunshan, 215300 Jiangsu Province PR China
9 9 2024
9 9 2024
2024
24 25121 5 2024
27 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Fournier’s Gangrene is a severe surgical infectious disease, and various risk factors can increase its mortality rate. The purpose of this study is to retrospectively analyze the clinical characteristics and laboratory data of Fournier’s Gangrene patients, followed by an analysis of mortality-related risk factors. This study has no secondary objectives.

Methods

This study included 46 hospitalized patients diagnosed with Fournier’s Gangrene at Suzhou Traditional Chinese Medicine Hospital from December 2013 to March 2024. Clinical data for all patients were extracted from the electronic medical records system. The collected data included gender, age, duration of illness, length of hospital stay, sites of infection involvement, comorbidities, white blood cell count, hematocrit, albumin, blood glucose, creatinine, serum sodium, serum potassium upon admission, microbial culture results, and patient outcomes (survival/death). The Simplified Fournier Gangrene Severe Index (SFGSI) was used to score all patients. Patients were categorized into survival and death groups based on clinical outcomes. Differences between categorical variables were compared using the χ² test or Fisher’s exact test. Differences between numerical variables were compared using Student’s t-test or the Mann-Whitney U test. Binary logistic regression was employed to analyze the risk factors for mortality in Fournier’s Gangrene.

Results

Among the 46 Fournier’s Gangrene patients, 39 were male (84.8%) and 7 were female (15.2%). The age ranged from 17 to 86 years, with a median age of 61 years. Fourteen cases (30.4%) were confined to the perianal area, 26 cases (56.5%) had fascial necrosis involving the perianal, perineal, and genital regions, while 6 cases (13.0%) extended to the abdominal wall. At a 3-month postoperative follow-up, 43 patients (93.5%) survived, while 3 patients (6.5%) died shortly after admission due to severe illness. Based on the outcome, patients were divided into survival and death groups with 43 and 3 cases, respectively. Significant differences were observed between the two groups in terms of age (P<0.05), extension to the abdominal wall (P<0.01), hematocrit (P<0.01), albumin (P<0.01), SFGSI (P<0.01), and SFGSI>2 (P<0.01). Binary logistic regression analysis indicated that decreased hematocrit was an independent risk factor for mortality in Fournier’s Gangrene patients.

Conclusion

This study provides a detailed analysis of the clinical characteristics and risk factors for mortality in Fournier’s Gangrene patients. The primary outcome of this study is that a decreased hematocrit is an independent risk factor for predicting mortality in FG patients. These findings offer valuable prognostic insights for clinicians, underscoring the importance of early identification and correction of reduced hematocrit to improve patient outcomes and survival rates.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12893-024-02547-4.

Keywords

Fournier’s Gangrene
Risk factors
Mortality
Simplified Fournier Gangrene severe index
Hematocrit
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Necrotizing fasciitis is a severe and rapidly progressing soft tissue infection, known for its highly invasive nature and high mortality rates [1, 2]. The hallmark of this disease is extensive fascial necrosis caused by microbial infection, rapidly leading to tissue destruction and toxic shock, posing a grave threat to the patient’s life [1–3]. Severe inflammation and the infectious process spread rapidly along the fascial plane, affecting adjacent soft tissues [2, 3]. The spread of inflammation and infection can lead to vascular thrombosis, subsequently causing ischemia and necrosis of adjacent soft tissues and fascia [4]. Therefore, the disease may initially go unnoticed or unrecognized, as there may be minimal or no skin manifestations in its early stages.

Necrotizing fasciitis occurring in the scrotum, perianal, and perineal regions is also known as Fournier’s Gangrene [1, 5]. Necrotizing fasciitis results from a synergistic infection of the fascia and subcutaneous tissues by both aerobic and anaerobic microorganisms [2, 6]. Literature reports that Gram-positive bacteria, such as Group A Streptococcus and Staphylococcus aureus, and Gram-negative bacteria, like Escherichia coli and Pseudomonas aeruginosa, are the most common bacteria isolated from wound cultures in Fournier’s Gangrene patients [7–9]. These bacteria can infect through various routes, including the urinary tract, gastrointestinal tract, or skin. The infectious and inflammatory processes spread rapidly along the Dartos, Colles, and Scarpa fasciae, early involving the abdominal wall [7, 10, 11]. Trauma, postoperative conditions, urinary tract infections, and other perineal infections like perianal abscesses often serve as the initial points of infection [1, 12]. Fournier’s Gangrene most commonly affects males over 50 years of age with diabetes mellitus [4, 7]. Fournier’s Gangrene is a surgical emergency often requiring urgent and multiple surgical debridements, antibiotic therapy, and supportive measures [5, 12].

Due to the rapid progression and high lethality of necrotizing fasciitis, prompt diagnosis and treatment are key to improving outcomes. Therefore, early identification and management of factors associated with mortality are crucial. Risk factors primarily involve host factors, pathogens, and environmental factors, including but not limited to diabetes, immunosuppressive states, history of trauma or surgery, and prolonged use of non-steroidal anti-inflammatory drugs [12, 13]. Understanding these risk factors aids in identifying high-risk populations and providing them with more targeted prevention and management strategies.

This study aims to conduct a retrospective analysis of clinical characteristics and laboratory data of Fournier’s Gangrene patients managed by the authors’ institution. We aim to analyze factors associated with mortality to enhance the clinical team’s understanding and comprehension of this disease. By doing so, we aim to provide robust evidence for the early identification of high-risk Fournier’s Gangrene patients, thereby reducing the harm to patients’ health and improving treatment success rates and survival rates.

Materials and methods

Study subjects

This is a retrospective, descriptive study that received approval from the Ethics Committee of Suzhou Traditional Chinese Medicine (TCM) Hospital (2024 Ethics Approval 004). We included 46 hospitalized patients diagnosed with Fournier’s Gangrene (FG) who were treated at Suzhou TCM Hospital from December 2013 to March 2024.

Inclusion criteria: Patients diagnosed with Fournier’s Gangrene who meet the following conditions: clinical presentation of localized cellulitis with significant systemic toxicity symptoms (high fever, significantly elevated white blood cell count, severe cases with altered mental status, rapid breathing, tachycardia); rapid progression of the condition, with the affected area showing quick swelling, crepitus, blackened and necrotic tissue, and significant pain; infection originating from the skin, urethra, or rectum [3].

Exclusion criteria: Patients with simple perianal, perineal, urethral, and scrotal abscesses without evidence of fascial necrosis; and patients with missing or incomplete data [1].

Among the included patients, 42 cases originated from the Department of Anorectal Surgery, indicating FG originating from perianal and perirectal abscesses. Four cases of FG originating from scrotal infections were from the Department of Urology.

Data collection

Clinical data for all patients, including medical history, physical examination, laboratory tests, imaging studies, and surgical records, were extracted from the electronic medical record system. The Fournier’s Gangrene Severity Index (FGSI) score is commonly used to evaluate the severity of FG [9, 11, 14]. This is one of the most widely used scoring systems and includes eight parameters: temperature, heart rate, respiratory rate, sodium, potassium, creatinine, white blood cell count, and hematocrit. The higher the score, the worse the prognosis. Scoring is done by assigning each parameter a score from 0 to 4 based on the degree of abnormality. The total score is the sum of all parameter scores. Patients with a total score greater than 9 typically have a severe condition and a poor prognosis. The simplified Fournier’s Gangrene Severity Index (SFGSI) is currently the most widely used [11, 14]. In addition, the age-adjusted Charlson Comorbidity Index (aCCI) is a widely used comorbidity scoring system. It quantifies comorbidities based on the number and severity of a patient’s disease and can be used to predict the risk of disease mortality [15]. The collected data included gender, age, duration of illness, length of hospital stay, sites of infection, comorbidities, white blood cell count, hematocrit, albumin, blood glucose, creatinine, serum sodium, serum potassium upon admission, microbial culture results, and patient outcomes (survival/death), among others. All patients were scored using the SFGSI and aCCI.

Treatment strategies

Based on the increasing understanding of FG, a high-level response was initiated for all FG patients upon admission to complete laboratory tests and CT scans as quickly as possible to assess the severity of the condition [16]. All FG patients underwent initial emergency surgical debridement and drainage under spinal or general anesthesia within 24 h of admission. The initial debridement and drainage were conducted under a multi-disciplinary team (MDT) approach. Depending on the affected areas, colorectal surgeons, urologists, and general surgeons performed debridement and drainage of the perianal, perineal, genital, and abdominal wall regions. Swab samples were collected from the wound edges for culture. Debridement was performed to remove necrotic tissue until fresh bleeding surfaces were exposed, typically requiring at least one debridement of necrotic tissue. Once diagnosed with FG, all patients received broad-spectrum antibiotic treatment. After microbial culture results were available, antibiotics were selected based on sensitivity testing [6]. Our experience suggests early and adequate use of imipenem/cilastatin. For patients with severe conditions, they were transferred to the intensive care unit (ICU) for mechanical ventilation and hemodynamic support after the initial debridement. None of the included patients underwent colostomy or cystostomy procedures.

After the initial thorough debridement, dressing changes were performed daily. The wounds were cleaned with povidone-iodine, saline, and 2% hydrogen peroxide, and then covered with povidone-iodine dressings [4]. During dressing changes, the progression of wound infection was observed. Depending on the progression of the infection, one or more additional debridements might be needed, which could typically be completed in the ward.

Statistical analysis

Statistical analysis was performed using IBM SPSS 26.0 software. Categorical variables were described using frequencies (n) and percentages (%). Numerical variables were expressed as mean ± standard deviation (SD) or median with interquartile range after the Kolmogorov-Smirnov normality test. Differences between categorical variables were compared using the χ² test or Fisher’s exact test. Differences between numerical variables were compared using the student’s t-test or Mann-Whitney U test. Binary logistic regression was used for analyzing risk factors associated with mortality [11, 17]. A p-value < 0.05 was considered statistically significant.

Results

Clinical characteristics of FG patients

As shown in Table 1, among the 46 FG patients, there were 39 males (84.8%) and 7 females (15.2%). The age ranged from 17 to 86 years with a median age of 61 years. The shortest duration of illness was 3 days, the longest was 30 days, and the median duration was 7 days. The shortest length of hospital stay was 2 days, the longest was 30 days, and the median stay was 14 days. Regarding the sites of necrotic lesions, 14 cases (30.4%) were localized to the perianal area, 26 cases (56.5%) had fascial necrosis involving the perianal, perineal, and genital regions, and 6 cases (13.0%) had fascial necrosis extending to the abdominal wall. There were 17 patients (37.0%) with hypertension and 17 patients (37.0%) with diabetes. Nine patients (19.6%) had both hypertension and diabetes, while one patient (2.2%) had both a hematologic disorder and diabetes. Twenty patients (43.5%) had no comorbidities. During a 3-month follow-up after surgery, 43 patients (93.5%) survived, while 3 patients (6.5%) died shortly after admission due to the severity of their condition. It is noteworthy that the three deceased patients had very short hospital stays, lasting 2 days, 3 days, and 5 days respectively.

Table 1 Clinical data of the Fournier’s Gangrene patients (n = 46)

Variables	Results	
Age (years)	61.0 (69.25–47.25)	
Gender		
   Male	39 (84.8%)	
   Female	7 (15.2%)	
Disease course (days)	7.0 (10.0–5.0)	
Length of hospitalization (days)	14.0 (18.25-10.0)	
Involved areas		
   Perianal	14 (30.4%)	
   Perianal, perineal and genital	26 (56.5%)	
   Perianal, perineal, genital and abdominal wall	6 (13.0%)	
Comorbidities		
   Hypertension	17 (37.0%)	
   Diabetes mellitus	17 (37.0%)	
   Inflammatory Bowel Disease (IBD)	0	
   Hematologic disorders	1 (2.2%)	
   Diabetes + Hypertension	9 (19.6%)	
   Diabetes + Hematologic disorders	1 (2.2%)	
   No comorbidities	20 (43.5%)	
Outcomes		
   Survived	43 (93.5%)	
   Died	3 (6.5%)	
The results are expressed as quartiles or as frequency and percentage

Analysis of laboratory data in FG patients

As shown in Table 2, after normality testing, the blood glucose and creatinine levels of the 46 included patients did not follow a normal distribution. The white blood cell count ranged from 6.63 × 10^9/L to 38.57 × 10^9/L, with an average of 16.5 ± 6.3 × 10^9/L. The hematocrit ranged from 20.3 to 47.8%, with an average of (37.0 ± 6.0) %. Albumin levels ranged from 21.0 g/L to 43.7 g/L, with an average of 32.5 ± 5.6 g/L. Serum sodium levels ranged from 126.6 mmol/L to 144.5 mmol/L, with an average of 135.8 ± 4.6 mmol/L. Serum potassium levels ranged from 2.96 mmol/L to 5.1 mmol/L, with an average of 3.8 ± 0.6 mmol/L. Blood glucose levels ranged from 4.48 mmol/L to 32.55 mmol/L, with a median of 7.91 mmol/L. Creatinine levels ranged from 47.0 umol/L to 294.3 umol/L, with a median of 80.1 umol/L. Bacterial cultures were performed on necrotic tissues from 38 patients (82.6%), with 28 cases (60.9%) yielding positive results. Among the cultured microorganisms, Escherichia coli was the most common, found in 19 cases (41.3%), followed by Klebsiella pneumoniae in 4 cases (8.7%).

Table 2 Laboratory data of the Fournier’s Gangrene patients (n = 46)

Variables	Results	
White blood cell count (×109/L)	16.5 ± 6.3	
Hematocrit (%)	37.0 ± 6.0	
Serum sodium (mmol/L)	135.8 ± 4.6	
Serum potassium (mmol/L)	3.8 ± 0.6	
Blood glucose (mmol/L)	7.91 (11.22–6.42)	
Creatinine (umol/L)	80.1 (136.35–65.15)	
Albumin (g/L)	32.5 ± 5.6	
Bacterial culture results		
   Escherichia coli	19 (41.3%)	
   Staphylococcus epidermidis	1 (2.2%)	
   Staphylococcus aureus	1 (2.2%)	
   Morganella morganii	1 (2.2%)	
   Klebsiella pneumoniae	4 (8.7%)	
   Enterococcus faecium + Klebsiella pneumoniae	1 (2.2%)	
   Streptococcus constellatus	1 (2.2%)	
   No bacterial growth observed	10 (21.7%)	
   No bacterial culture performed	8 (17.4%)	
The results are expressed as mean ± standard deviation, quartiles, or as frequency and percentage

Comparison of clinical and laboratory data based on patient outcomes

Based on outcomes (survival/death), the 46 patients were divided into two groups: the survival group with 43 cases and the death group with 3 cases. As shown in Table 3, after comparison, significant differences were found between the two groups in terms of age (P<0.05), length of hospital stay (P<0.001), extension to the abdominal wall (P<0.01), hematocrit (P<0.01), albumin (P<0.01), SFGSI (P<0.01), and SFGSI>2 (P<0.01). These results suggest that older age, extension to the abdominal wall, lower hematocrit, and higher SFGSI are risk factors for mortality in FG patients. Because the three patients in the death group died shortly after admission due to the severity of their condition, a short hospitalization duration cannot be proven as an independent risk factor associated with mortality. No significant differences were observed in the remaining variables.

Table 3 Distribution of clinical and laboratory data variables stratified by mortality

Variables	Survivors (n = 43)	Death (n = 3)	P	
Age (years) *	58.0	76.0	0.038	
Male	38 (88.4%)	1 (33.3%)	0.056	
Disease course (days) *	7.0	6.0	0.801	
Length of hospitalization (days) *	14.0	3.0	<0.001	
Extension to the abdominal wall	3 (7.0%)	3 (100%)	0.001	
Hypertension	16 (37.2%)	1 (33.3%)	1.000	
Diabetes mellitus	16 (37.2%)	1 (33.3%)	1.000	
Diabetes + Hypertension	8 (18.6%)	1 (33.3%)	0.488	
White blood count (×109/L)	16.3 ± 6.2	19.3 ± 8.4	0.439	
Hematocrit (%)	37.7 ± 5.5	26.6 ± 2.9	0.001	
Serum sodium (mmol/L)	135.9 ± 4.5	134.9 ± 6.4	0.715	
Serum potassium (mmol/L)	3.8 ± 0.5	4.3 ± 0.8	0.083	
Blood glucose (mmol/L) *	7.6	8.9	0.548	
Creatinine (umol/L) *	80.0	201.0	0.276	
Albumin (g/L)	33.1 ± 5.2	23.5 ± 2.3	0.003	
SFGSI *	1.0	5.0	0.006	
SFGSI>2	5 (11.6%)	3 (100%)	0.004	
aCCI *	3.0	4.0	0.076	
The results are expressed as mean ± standard deviation, median, or as frequency and percentage

* Some data that do not follow a normal distribution cannot be represented by quartiles due to the small sample size in the deceased group; therefore, the median is used for representation

Binary logistic regression analysis

For the variables showing differences in Table 3, binary logistic regression was employed to further analyze the risk factors related to FG mortality. Initially, a univariate regression analysis was conducted using age, length of hospital stay, involvement of the abdominal wall, hematocrit, albumin, and SFGSI>2 as independent variables, and mortality as the dependent variable. This was followed by a multivariate regression analysis where the variables showing statistical differences in the univariate analysis were used as independent variables to explore the independent risk factors affecting mortality after adjusting for confounding factors. As shown in Table 4, The binary logistic regression analysis showed that hematocrit was the variable with a significant difference. The univariate regression analysis found a 95% confidence interval (CI) for hematocrit of 0.597–0.953, with an odds ratio (OR) of 0.754 and a p-value of 0.018, which is less than 0.05. The multivariate regression analysis found a 95% CI for hematocrit of 0.556–0.987, with an adjusted odds ratio (AOR) of 0.740 and a p-value of 0.040, which is also less than 0.05. According to Table 4, for every unit increase in hematocrit, there was a significant 24.6% decrease in the likelihood of mortality in FG patients. None of the other factors showed statistical significance as predictors of mortality. Even after adjusting for age as a confounding factor, the relationship between hematocrit and mortality remained significant. Specifically, for every unit increase in hematocrit, there was a significant 26% decrease in the likelihood of mortality in FG patients.

Table 4 Results of binary logistic regression analysis

Variables	Univariate regression	Multivariate regression	
OR(95%CI)	P	AOR(95%CI)	P	
Age	1.155(0.987–1.352)	0.072	NA		
Length of hospitalization	0.000(0.000–0.000)	0.989	NA		
Extension to the abdominal wall	1,615,474,898(0.00–0.000)	0.997	NA		
Hematocrit	0.754(0.597–0.953)	0.018	0.740(0.556–0.987)	0.040	
Albumin	0.336(0.102–1.107)	0.073	NA		
SFGSI>2	969284901.8(0.00–0.000)	0.997	NA		
OR = Odds ratio; CI = Confidence interval; SFGSI = Simplified Fournier Gangrene Severe Index; AOR = Adjusted odds ratio

We divided the 46 patients into two groups based on whether their hematocrit levels were below 30 (%) and compared the survival rates between the two groups. Statistical analysis indicated a significant difference in survival rates between the groups (P = 0.001). Similarly, we divided the 46 patients into two groups based on whether their hematocrit levels were below 35 (%) and compared their survival rates. The analysis showed a difference in survival rates between the groups (P = 0.037). These results further support the robustness of our conclusion that decreased hematocrit is an independent risk factor for mortality in FG patients (Supplementary Tables 1, 2).

Discussion

Fournier’s gangrene is a severe surgical infection that is relatively rare. Over an 11-year period, our hospital treated 46 cases of FG. The disease predominantly affects males, with our results showing that males accounted for 84.8% of FG patients, consistent with existing literature [10, 11]. Early diagnosis, proper management of predisposing factors, and aggressive surgical debridement can improve clinical outcomes [18]. Previous studies have reported varying mortality rates for this disease, ranging from 20 to 80% [18]. With increased attention to the disease and advancements in treatment, the reported mortality rate for FG now ranges between 7.5% and 16% [12]. Our study found a mortality rate of 6.5% for FG, consistent with the most recent literature.

Several studies have identified the main risk factors for the occurrence of FG, including diabetes, alcohol abuse, obesity, immunosuppression, hypertension, hematological diseases, perianal and rectal abscesses, perineal infections, and trauma [12, 13, 19]. Our study found that 37.0% of patients had hypertension, and 37.0% had diabetes. Additionally, 19.6% of the patients had both hypertension and diabetes. Among the 46 FG patients in our study, 91.3% originated from perianal abscesses, while 8.7% were from scrotal infections. These clinical data are consistent with what is described in the literature.

Studies have reported that risk factors associated with mortality in FG include advanced age, diabetes, infection extending to the abdominal wall, low hematocrit, abnormal serum potassium levels, and elevated creatinine levels [11, 17]. Due to the high mortality rate of FG, several assessment scales have been used to evaluate the severity of the disease and prognosis in patients. Currently, used clinical assessment scales include FGSI, ACCI, LRINEC, and UFGSI, among which FGSI is the most commonly used [11, 14, 20]. Research has shown that the sensitivity and specificity of FGSI in predicting mortality are both between 65% and 100% [14]. In 2014, Lin et al. developed the SFGSI based on the FGSI scale, incorporating three laboratory parameters: serum potassium, creatinine, and hematocrit. They compared it with other assessment scales and found that SFGSI is user-friendly with good sensitivity (87%) and specificity (77%) in predicting mortality, effectively identifying patients with poor prognosis [14]. Our results show that higher age, involvement of the abdominal wall, lower hematocrit, lower serum albumin, and higher SFGSI scores were observed in the non-survival group. Elderly patients experience a gradual decline in physiological function and a weakening of the immune system, which may increase the risk of infection and reduce their ability to fight off infections. Additionally, older patients often have multiple chronic conditions, such as diabetes and hypertension, which could exacerbate the severity and prognosis of Fournier’s gangrene. Abdominal wall involvement often indicates a large extent of the lesion that has spread to deeper tissues, resulting in more severe tissue necrosis and infection, and a poor prognosis. The involvement of the abdominal wall as a predictive factor for mortality has been described in related studies [13, 21]. Hypoalbuminemia was correlated with mortality in FG. Lin et al. reported significant differences in admission hematocrit and serum albumin levels between the survival and non-survival groups in FG patients [20]. The C-reactive protein/albumin ratio (CAR) has been shown to correlate with the severity of infection and serves as an effective inflammatory marker to predict prognosis [22]. Özgül et al.‘s study demonstrated that the CRP/albumin ratio can be used to predict FG-related mortality [23]. SFGSI is an important tool for assessing the severity and prognosis of patients with Fournier’s gangrene [11, 14]. In our study, SFGSI showed a higher trend in the mortality group, with all deceased patients having an SFGSI > 2, reflecting a severe decline in the patient’s overall condition. However, our results showed no significant differences in creatinine and serum potassium levels between the two groups. The mean and p-value (0.083) for serum potassium suggest a tendency toward statistical difference between the groups. Although the median creatinine level in the mortality group was noticeably higher than that in the survival group, the p-value (0.276) > 0.05. We believe that the lack of significant differences in serum potassium and creatinine between the two groups may be due to the small sample size and resulting bias in the study results.

The results of both univariate and multivariate regression analyses in this study showed that a decreased hematocrit level is a risk factor for mortality in FG patients. The statistical analysis demonstrated that lower hematocrit levels were significantly associated with increased mortality risk in Fournier’s Gangrene (univariate regression: OR 0.754, 95% CI: 0.597–0.953, p = 0.018; multivariate regression: AOR 0.740, 95% CI: 0.556–0.987, p = 0.040). Both univariate and multivariate regression analyses for the variable hematocrit showed p-values less than 0.05. This finding underscores the importance of monitoring and managing hematocrit levels in these patients to improve survival outcomes. Regardless of whether it’s FGSI or SFGSI, hematocrit remains an important laboratory parameter for predicting the prognosis of FG [12, 14]. Cen et al. conducted a retrospective analysis of 111 cases of necrotizing soft tissue infections to investigate the risk factors associated with mortality and amputation in these patients. Their study showed that high LRINEC scores, elevated WBC counts, low hematocrit (HCT), and multiple surgeries were associated with increased mortality rates [10]. Similar results have been corroborated in other studies [13, 17, 24, 25].

This study has several limitations. First, we recruited a relatively small sample of 46 FG patients over an 11-year period, which might introduce potential biases into our results. Second, this was a retrospective study conducted at a single center. The small sample size and single-center design limit the generalizability of our findings. The small sample size may affect the representativeness and accuracy of the results. Small sample data often fails to meet the traditional statistical test hypothesis, and special statistical methods are required for analysis, increasing the research’s complexity and uncertainty. In addition, single-center studies may have a single sample source and lack of diversity, further increasing the difficulty of statistical inference. Therefore, large-scale multicenter studies are needed to minimize potential biases as much as possible and validate these results in the future. Our findings are based on our clinical experience in managing FG patients, so we cannot generalize our findings to other populations. However, our experience and findings can serve as a valuable reference for other clinical teams tasked with managing FG.

Conclusions

This study provides a comprehensive analysis of the clinical characteristics and mortality risk factors in FG patients. The primary outcome of this study is that a decreased hematocrit level is an independent risk factor for predicting mortality in FG patients. These findings offer crucial prognostic guidance for clinicians, underscoring the importance of early identification and correction of decreased hematocrit levels. Timely correction of low hematocrit levels may improve patient outcomes and survival rates. Of course, this requires large-scale, multicenter studies to further validate the findings. Future research endeavors should delve deeper into investigating the correlation between hematocrit levels and prognosis in FG, while also striving to identify more efficacious interventions aimed at improving the quality of life and survival rates of affected individuals.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Acknowledgements

Not applicable.

Author contributions

Zongqi He, Shuguang Zhen, and Bensheng Wu conceived and designed the study. Qingyun You, Jing Guan, Jun Du, and Yangyang Miao collected all clinical and laboratory data and were responsible for the literature review. Zongqi He, Xinxin Bai, and Yuhua Ma conducted the statistical analysis. All authors contributed significantly to drafting and revising the manuscript. All authors gave final approval for the manuscript to be published.

Funding

No funding was received.

Data availability

All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

Declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Suzhou Traditional Chinese Medicine Hospital (2024 Ethics Approval 004). This study was based on retrospective data collected by reviewing participants’ medical records. Informed consent from participants was waived due to the study’s retrospective nature. Additionally, some participants have passed away due to the severity of their illness, making it impossible to obtain informed consent from them.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

FG Fournier’s Gangrene

TCM Traditional Chinese medicine

SFGSI Simplified Fournier Gangrene severe index

FGSI Fournier Gangrene severe index

aCCI/ACCI Age-adjusted Charlson comorbidity index

MDT Multi-Disciplinary team

ICU Intensive care unit

CI Confidence interval

OR Odds ratio

AOR Adjusted odds ratio

LRINEC Laboratory risk indicator for necrotizing fasciitis

UFGSI Uludag Fournier’s Gangrene severity index

CAR C-Reactive protein/albumin ratio

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Qingyun You and Jing Guan contributed equally to this work.
==== Refs
References

1. Ozkan OF Koksal N Altinli E Celik A Uzun MA Cıkman O Fournier’s gangrene current approaches Int Wound J 2016 13 713 6 10.1111/iwj.12357 25145578
Ozkan OF, Koksal N, Altinli E, Celik A, Uzun MA, Cıkman O, et al. Fournier’s gangrene current approaches. Int Wound J. 2016;13:713–6.25145578 10.1111/iwj.12357
2. Hua C Urbina T Bosc R Parks T Sriskandan S De Prost N Necrotising soft-tissue infections Lancet Infect Dis 2023 23 e81 94 10.1016/S1473-3099(22)00583-7 36252579
Hua C, Urbina T, Bosc R, Parks T, Sriskandan S, De Prost N, et al. Necrotising soft-tissue infections. Lancet Infect Dis. 2023;23:e81–94.36252579 10.1016/S1473-3099(22)00583-7
3. Voelzke BB Hagedorn JC Presentation and diagnosis of Fournier Gangrene Urology 2018 114 8 13 10.1016/j.urology.2017.10.031 29146218
Voelzke BB, Hagedorn JC. Presentation and diagnosis of Fournier Gangrene. Urology. 2018;114:8–13.29146218 10.1016/j.urology.2017.10.031
4. Taken K, Oncü MR, Ergun M, Eryılmaz R, Demir CY, Demir M et al. Fournier’s gangrene: causes, presentation and survival of sixty-five patients. Pak J Med Sci. 2016;32.
5. Tarasconi A Perrone G Davies J Coimbra R Moore E Azzaroli F Anorectal emergencies: WSES-AAST guidelines World J Emerg Surg 2021 16 48 10.1186/s13017-021-00384-x 34530908
Tarasconi A, Perrone G, Davies J, Coimbra R, Moore E, Azzaroli F, et al. Anorectal emergencies: WSES-AAST guidelines. World J Emerg Surg. 2021;16:48.34530908 10.1186/s13017-021-00384-x
6. Thwaini A Khan A Malik A Cherian J Barua J Shergill I Fournier’s gangrene and its emergency management Postgrad Med J 2006 82 516 9 10.1136/pgmj.2005.042069 16891442
Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, et al. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006;82:516–9.16891442 10.1136/pgmj.2005.042069
7. Montrief T Long B Koyfman A Auerbach J Fournier Gangrene: a review for emergency clinicians J Emerg Med 2019 57 488 500 10.1016/j.jemermed.2019.06.023 31472943
Montrief T, Long B, Koyfman A, Auerbach J. Fournier Gangrene: a review for emergency clinicians. J Emerg Med. 2019;57:488–500.31472943 10.1016/j.jemermed.2019.06.023
8. Short B Fournier gangrene: an historical reappraisal Intern Med J 2018 48 1157 60 10.1111/imj.14031 30182399
Short B. Fournier gangrene: an historical reappraisal. Intern Med J. 2018;48:1157–60.30182399 10.1111/imj.14031
9. Warli SM Pakpahan KA Nasution R Kadar DD Adhyatma KP Role of SFGSI, microbial culture and qSOFA as predictive factors in determining the survival rate in Fournier Gangrene patient SMJ 2024 45 230 4 10.15537/smj.2024.45.3.20230036
Warli SM, Pakpahan KA, Nasution R, Kadar DD, Adhyatma KP. Role of SFGSI, microbial culture and qSOFA as predictive factors in determining the survival rate in Fournier Gangrene patient. SMJ. 2024;45:230–4.10.15537/smj.2024.45.3.20230036
10. Cen H, Jin R, Yin J, Wang X. Risk Factors for Predicting Mortality and Amputation of Patients with Necrotizing Soft-Tissue Infections: Retrospective Analysis of 111 Cases from a Single Medical Center. Emerg Med Int. 2023; 2023:6316896.
11. Tenório CEL Lima SVC Albuquerque AVD Cavalcanti MP Teles F Risk factors for mortality in fournier’s gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI) Int braz j urol 2018 44 95 101 10.1590/s1677-5538.ibju.2017.0193 28853819
Tenório CEL, Lima SVC, Albuquerque AVD, Cavalcanti MP, Teles F. Risk factors for mortality in fournier’s gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI). Int braz j urol. 2018;44:95–101.28853819 10.1590/s1677-5538.ibju.2017.0193
12. Hagedorn JC Wessells H A contemporary update on Fournier’s gangrene Nat Rev Urol 2017 14 205 14 10.1038/nrurol.2016.243 27958393
Hagedorn JC, Wessells H. A contemporary update on Fournier’s gangrene. Nat Rev Urol. 2017;14:205–14.27958393 10.1038/nrurol.2016.243
13. Tarchouli M Bounaim A Essarghini M Ratbi MB Belhamidi MS Bensal A Analysis of prognostic factors affecting mortality in Fournier’s gangrene: a study of 72 cases Can Urol Assoc J 2015 9 E800 804 10.5489/cuaj.3192 26600888
Tarchouli M, Bounaim A, Essarghini M, Ratbi MB, Belhamidi MS, Bensal A, et al. Analysis of prognostic factors affecting mortality in Fournier’s gangrene: a study of 72 cases. Can Urol Assoc J. 2015;9:E800–804.26600888 10.5489/cuaj.3192
14. Lin T Ou C Tzai T Tong Y Chang C Cheng H Validation and simplification of F ournier’s gangrene severity index Int J Urol 2014 21 696 701 10.1111/iju.12426 24635453
Lin T, Ou C, Tzai T, Tong Y, Chang C, Cheng H, et al. Validation and simplification of F ournier’s gangrene severity index. Int J Urol. 2014;21:696–701.24635453 10.1111/iju.12426
15. Azmi YA Alkaff FF Renaldo J Wirjopranoto S Prasetiyanti R Soetanto KM Comparison of different scoring systems for predicting in-hospital mortality for patients with Fournier gangrene World J Urol 2023 41 2751 7 10.1007/s00345-023-04552-3 37580468
Azmi YA, Alkaff FF, Renaldo J, Wirjopranoto S, Prasetiyanti R, Soetanto KM, et al. Comparison of different scoring systems for predicting in-hospital mortality for patients with Fournier gangrene. World J Urol. 2023;41:2751–7.37580468 10.1007/s00345-023-04552-3
16. Levenson RB, Singh AK, Novelline RA. Fournier Gangrene: Role of Imaging. RadioGraphics. 2008; 28:519–28.
17. García Marín A Turégano Fuentes F Cuadrado Ayuso M Andueza Lillo JA Cano Ballesteros JC Pérez López M. Predictive factors for mortality in Fournier’ gangrene: a series of 59 cases Cir Esp 2015 93 12 7 10.1016/j.ciresp.2014.03.017 24862684
García Marín A, Turégano Fuentes F, Cuadrado Ayuso M, Andueza Lillo JA, Cano Ballesteros JC. Pérez López M. Predictive factors for mortality in Fournier’ gangrene: a series of 59 cases. Cir Esp. 2015;93:12–7.24862684 10.1016/j.ciresp.2014.03.017
18. Kuzaka B Wróblewska MM Borkowski T Kawecki D Kuzaka P Młynarczyk G Fournier’s Gangrene: clinical presentation of 13 cases Med Sci Monit 2018 24 548 55 10.12659/MSM.905836 29374769
Kuzaka B, Wróblewska MM, Borkowski T, Kawecki D, Kuzaka P, Młynarczyk G, et al. Fournier’s Gangrene: clinical presentation of 13 cases. Med Sci Monit. 2018;24:548–55.29374769 10.12659/MSM.905836
19. El-Qushayri AE Khalaf KM Dahy A Mahmoud AR Benmelouka AY Ghozy S Fournier’s gangrene mortality: a 17-year systematic review and meta-analysis Int J Infect Dis 2020 92 218 25 10.1016/j.ijid.2019.12.030 31962181
El-Qushayri AE, Khalaf KM, Dahy A, Mahmoud AR, Benmelouka AY, Ghozy S, et al. Fournier’s gangrene mortality: a 17-year systematic review and meta-analysis. Int J Infect Dis. 2020;92:218–25.31962181 10.1016/j.ijid.2019.12.030
20. Lin E Yang S Chiu AW Chow Y-C Chen M Lin W-C Is Fournier’s gangrene severity index useful for predicting outcome of Fournier’s gangrene? Urol Int 2005 75 119 22 10.1159/000087164 16123564
Lin E, Yang S, Chiu AW, Chow Y-C, Chen M, Lin W-C, et al. Is Fournier’s gangrene severity index useful for predicting outcome of Fournier’s gangrene? Urol Int. 2005;75:119–22.16123564 10.1159/000087164
21. Tuncel A Aydin O Tekdogan U Nalcacioglu V Capar Y Atan A Fournier’s gangrene: three years of experience with 20 patients and validity of the Fournier’s Gangrene Severity Index score Eur Urol 2006 50 838 43 10.1016/j.eururo.2006.01.030 16513250
Tuncel A, Aydin O, Tekdogan U, Nalcacioglu V, Capar Y, Atan A. Fournier’s gangrene: three years of experience with 20 patients and validity of the Fournier’s Gangrene Severity Index score. Eur Urol. 2006;50:838–43.16513250 10.1016/j.eururo.2006.01.030
22. Yılmaz EM Kandemir A Significance of red blood cell distribution width and C-reactive protein/albumin levels in predicting prognosis of acute pancreatitis Ulus Travma Acil Cerrahi Derg 2018 24 528 31 30516251
Yılmaz EM, Kandemir A. Significance of red blood cell distribution width and C-reactive protein/albumin levels in predicting prognosis of acute pancreatitis. Ulus Travma Acil Cerrahi Derg. 2018;24:528–31.30516251
23. Özgül H Uzmay Y The role of C-reactive protein albumin ratio for predicting mortality in patients with Fournier’s gangrene Ulus Travma Acil Cerrahi Derg 2023 29 1242 7 10.14744/tjtes.2023.08903 37889021
Özgül H, Uzmay Y. The role of C-reactive protein albumin ratio for predicting mortality in patients with Fournier’s gangrene. Ulus Travma Acil Cerrahi Derg. 2023;29:1242–7.37889021 10.14744/tjtes.2023.08903
24. Ioannidis O Kitsikosta L Tatsis D Skandalos I Cheva A Gkioti A Fournier’s Gangrene: lessons learned from Multimodal and Multidisciplinary Management of Perineal necrotizing Fasciitis Front Surg 2017 4 36 10.3389/fsurg.2017.00036 28740847
Ioannidis O, Kitsikosta L, Tatsis D, Skandalos I, Cheva A, Gkioti A, et al. Fournier’s Gangrene: lessons learned from Multimodal and Multidisciplinary Management of Perineal necrotizing Fasciitis. Front Surg. 2017;4:36.28740847 10.3389/fsurg.2017.00036
25. Ansari Djafari A, Rahavian A, Javanmard B, Montazeri S, Shahabi V, Hojjati SA et al. Factors related to mortality in patients with Fournier’s Gangrene or Necrotising Fasciitis; a 10-year cross-sectional study. Arch Acad Emerg Med. 2021;9: e33.
